gabexate has been researched along with Nephrosclerosis in 1 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
Nephrosclerosis: Hardening of the KIDNEY due to infiltration by fibrous connective tissue (FIBROSIS), usually caused by renovascular diseases or chronic HYPERTENSION. Nephrosclerosis leads to renal ISCHEMIA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Morinaga, J | 1 |
| Kakizoe, Y | 1 |
| Miyoshi, T | 1 |
| Onoue, T | 1 |
| Ueda, M | 1 |
| Mizumoto, T | 1 |
| Yamazoe, R | 1 |
| Uchimura, K | 1 |
| Hayata, M | 1 |
| Shiraishi, N | 1 |
| Adachi, M | 1 |
| Sakai, Y | 1 |
| Tomita, K | 1 |
| Kitamura, K | 1 |
1 other study available for gabexate and Nephrosclerosis
| Article | Year |
|---|---|
The antifibrotic effect of a serine protease inhibitor in the kidney.
Topics: Animals; Cell Line; Chemokine CCL2; Esters; Fibroblasts; Gabexate; Guanidines; Macrophages; Nephrosc | 2013 |